Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease.

You SC, Walsh CM, Chiodo LA, Ketelle R, Miller BL, Kramer JH.

J Alzheimers Dis. 2015;48(3):863-9. doi: 10.3233/JAD-150018.

2.

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R.

Neuropsychopharmacology. 2003 Aug;28(8):1400-11. Epub 2003 May 21.

3.
5.

Cholecystokinin mobilizes intracellular Ca2+ in hybrid N18TG2 X mesencephalon (MES-23.5) cells.

Parikh HN, Chiodo LA, Koss J, Crawford GD, Freeman AS.

Synapse. 1995 Nov;21(3):278-80. No abstract available.

PMID:
8578438
6.

Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.

Pitts DK, Wang L, Kelland MD, Freeman AS, Chiodo LA.

J Pharmacol Exp Ther. 1995 Oct;275(1):412-21.

PMID:
7562579
7.
8.

Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.

Shen RY, Altar CA, Chiodo LA.

Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8920-4.

11.
12.

Further characterization of the effects of BMY 14802 on dopamine neuronal activity.

Zhang J, Chiodo LA, Freeman AS.

Synapse. 1993 Dec;15(4):276-84.

PMID:
7908761
15.

Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells.

Castellano MA, Liu LX, Monsma FJ Jr, Sibley DR, Kapatos G, Chiodo LA.

Mol Pharmacol. 1993 Sep;44(3):649-56.

PMID:
8371717
16.

Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons.

Zhang J, Chiodo LA, Wettstein JG, Junien JL, Freeman AS.

Synapse. 1993 Mar;13(3):223-30.

PMID:
8497808
17.

Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.

Pitts DK, Kelland MD, Freeman AS, Chiodo LA.

J Pharmacol Exp Ther. 1993 Feb;264(2):616-21.

PMID:
8094749
18.

Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons.

Zhang J, Chiodo LA, Freeman AS.

Eur J Pharmacol. 1993 Jan 19;230(3):371-4.

PMID:
8440313
19.

Ascending afferent regulation of rat midbrain dopamine neurons.

Kelland MD, Freeman AS, Rubin J, Chiodo LA.

Brain Res Bull. 1993;31(5):539-46.

PMID:
8495379
20.

Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.

Zhang J, Chiodo LA, Freeman AS.

Brain Res. 1992 Sep 11;590(1-2):153-63.

PMID:
1422830
22.
23.

Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons.

Zhang J, Chiodo LA, Wettstein JG, Junien JL, Freeman AS.

Synapse. 1992 Aug;11(4):267-78.

PMID:
1323882
24.

Dopamine autoreceptor signal transduction in the DA cell body: a "current view".

Chiodo LA.

Neurochem Int. 1992 Mar;20 Suppl:81S-84S. Review. No abstract available.

PMID:
1365461
25.

Midbrain dopamine system electrophysiological functioning: a review and new hypothesis.

Bunney BS, Chiodo LA, Grace AA.

Synapse. 1991 Oct;9(2):79-94. Review.

PMID:
1821487
26.

Dissociative anesthesia and striatal neuronal electrophysiology.

Kelland MD, Chiodo LA, Freeman AS.

Synapse. 1991 Sep;9(1):75-8.

PMID:
1796354
27.

Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation.

Freeman AS, Chiodo LA, Lentz SI, Wade K, Bannon MJ.

Brain Res. 1991 Aug 2;555(2):281-7.

PMID:
1682000
28.

Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.

Kelland MD, Zhang J, Chiodo LA, Freeman AS.

Synapse. 1991 Jun;8(2):137-43.

PMID:
1882334
29.

Repeated SKF 38393 and nigrostriatal system neuronal responsiveness: functional down-regulation is followed by up-regulation after withdrawal.

Kelland MD, Pitts DK, Freeman AS, Chiodo LA.

Naunyn Schmiedebergs Arch Pharmacol. 1991 May;343(5):447-57.

PMID:
1881456
30.

Effects of the CCK-A receptor antagonist CR 1409 on the activity of rat midbrain dopamine neurons.

Zhang J, Chiodo LA, Freeman AS.

Peptides. 1991 Mar-Apr;12(2):339-43.

PMID:
2067986
31.

Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.

Kelland MD, Freeman AS, LeWitt PA, Chiodo LA.

J Pharmacol Exp Ther. 1990 Oct;255(1):276-84.

PMID:
1976800
32.

The effects of the phencyclidine analogs BTCP and TCP on nigrostriatal dopamine neuronal activity.

Rouillard C, Chiodo LA, Freeman AS.

Eur J Pharmacol. 1990 Jul 3;182(2):227-35.

PMID:
2397741
33.
34.

Statistical analysis of dose-response curves in extracellular electrophysiological studies of single neurons.

Pitts DK, Kelland MD, Shen RY, Freeman AS, Chiodo LA.

Synapse. 1990;5(4):281-93.

PMID:
2360196
35.

Dopamine neuron ontogeny: electrophysiological studies.

Pitts DK, Freeman AS, Chiodo LA.

Synapse. 1990;6(4):309-20.

PMID:
1981111
36.

Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.

Kelland MD, Chiodo LA, Freeman AS.

Synapse. 1990;6(2):207-9. No abstract available.

PMID:
1978421
37.
38.

CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.

Meltzer LT, Christoffersen CL, Heffner TG, Freeman AS, Chiodo LA.

J Pharmacol Exp Ther. 1989 Oct;251(1):123-30.

PMID:
2571714
39.

Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.

Freeman AS, Kelland MD, Rouillard C, Chiodo LA.

J Pharmacol Exp Ther. 1989 Jun;249(3):790-7.

PMID:
2567352
40.

Repeated amphetamine: reduced dopamine neuronal responsiveness to apomorphine but not quinpirole.

Pitts DK, Freeman AS, Kelland MD, Chiodo LA.

Eur J Pharmacol. 1989 Mar 14;162(1):167-71.

PMID:
2566494
41.
43.
44.
45.

Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.

Chiodo LA.

Neurosci Biobehav Rev. 1988 Spring;12(1):49-91. Review.

PMID:
3287242
46.
48.

Electrophysiological studies on the specificity of the cholecystokinin antagonist proglumide.

Chiodo LA, Freeman AS, Bunney BS.

Brain Res. 1987 May 5;410(2):205-11.

PMID:
3036308
50.

Supplemental Content

Loading ...
Support Center